Clinical trial
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
NCT03421132 is registered in ClinicalTrials.gov with Horizon Health Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
- Lead sponsor
- Horizon Health Network
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 20, 2018
- Completion date
- March 31, 2026
- Enrollment
- 96 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.